BDSI settles patent litigation with generic giant Teva

Raleigh-based BioDelivery Sciences International (Nasdaq: BDSI) has reached a settlement agreement with generic manufacturing giant Teva Pharmaceuticals.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.